FI962599A0 - Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksi - Google Patents
Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksiInfo
- Publication number
- FI962599A0 FI962599A0 FI962599A FI962599A FI962599A0 FI 962599 A0 FI962599 A0 FI 962599A0 FI 962599 A FI962599 A FI 962599A FI 962599 A FI962599 A FI 962599A FI 962599 A0 FI962599 A0 FI 962599A0
- Authority
- FI
- Finland
- Prior art keywords
- chiral
- preparation
- intermediates
- enantioselective process
- triaryl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939326173A GB9326173D0 (en) | 1993-12-22 | 1993-12-22 | Chemical compounds and process |
| PCT/GB1994/002799 WO1995017386A1 (en) | 1993-12-22 | 1994-12-22 | An enantioselective process for the preparation of chiral triaryl derivatives and chiral intermediates for use therein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI962599L FI962599L (fi) | 1996-06-20 |
| FI962599A7 FI962599A7 (fi) | 1996-06-20 |
| FI962599A0 true FI962599A0 (fi) | 1996-06-20 |
Family
ID=10747020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI962599A FI962599A0 (fi) | 1993-12-22 | 1994-12-22 | Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksi |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5608070A (cs) |
| EP (1) | EP0736010A1 (cs) |
| JP (1) | JPH09510691A (cs) |
| KR (1) | KR100328191B1 (cs) |
| AU (1) | AU689837B2 (cs) |
| CA (1) | CA2177817A1 (cs) |
| CZ (1) | CZ294296B6 (cs) |
| FI (1) | FI962599A0 (cs) |
| GB (2) | GB9326173D0 (cs) |
| HU (1) | HUT76284A (cs) |
| NZ (1) | NZ277529A (cs) |
| WO (1) | WO1995017386A1 (cs) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
| GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9326600D0 (en) * | 1993-12-22 | 1994-03-02 | Celltech Ltd | Chemical compounds |
| ATE260911T1 (de) * | 1993-12-22 | 2004-03-15 | Celltech R&D Ltd | Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe |
| US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| GB9412573D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412571D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| US5710170A (en) * | 1995-12-15 | 1998-01-20 | Merck Frosst Canada, Inc. | Tri-aryl ethane derivatives as PDE IV inhibitors |
| AU707574B2 (en) * | 1995-12-15 | 1999-07-15 | Merck Frosst Canada & Co. | Tri-aryl ethane derivatives as PDE IV inhibitors |
| GB9603723D0 (en) * | 1996-02-22 | 1996-04-24 | Merck & Co Inc | Diphenyl pyridyl derivatives as pde iv inhibitors |
| GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526243D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| AR006550A1 (es) * | 1996-04-17 | 1999-09-08 | Merck & Co Inc | Metodo de preparacion de inhibidores de fosfodiesterasa iv |
| GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
| US5808082A (en) * | 1996-05-08 | 1998-09-15 | Merck & Co., Inc. | Method of preparing phosphodiesterase IV inhibitors |
| JP2000510120A (ja) * | 1996-05-08 | 2000-08-08 | メルク エンド カンパニー インコーポレーテッド | ホスホジエステラーゼｉｖ阻害剤の製造法 |
| GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
| TW508353B (en) * | 1996-09-17 | 2002-11-01 | Merck & Co Inc | Method of preparing phosphodiesterase IV inhibitors |
| AU4269597A (en) * | 1996-09-17 | 1998-04-14 | Merck & Co., Inc. | Process for bioreduction of bisaryl ketone to bisaryl alcohol |
| US5900368A (en) * | 1996-09-17 | 1999-05-04 | Merck & Co., Inc. | Process for bioreduction of bisaryl ketone to bisaryl alcohol |
| DE69712631D1 (de) * | 1996-09-17 | 2002-06-20 | Merck & Co Inc | Verfahren zur herstellung von phosphodiesterase iv inhibitoren |
| GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
| US6057329A (en) * | 1996-12-23 | 2000-05-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives |
| GB9705361D0 (en) * | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| US6943191B1 (en) | 1998-02-27 | 2005-09-13 | The United States Of America As Represented By The Department Of Health And Human Services | Disubstituted lavendustin A analogs and pharmaceutical composition comprising the analogs |
| US6316434B1 (en) | 1999-03-03 | 2001-11-13 | Merck Frosst Canada & Co. | Assay for emetic activity |
| US6200993B1 (en) * | 1999-05-05 | 2001-03-13 | Merck Frosst Canada & Co. | Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| US6316472B1 (en) * | 1999-05-13 | 2001-11-13 | Merck Frosst Canada & Co. | Heterosubstituted pyridine derivatives as PDE 4 inhibitors |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| EP2266607A3 (en) | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunoconjugates for treating cancer |
| GB9924862D0 (en) * | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
| US6410563B1 (en) | 1999-12-22 | 2002-06-25 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| MY123585A (en) * | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
| US6639077B2 (en) | 2000-03-23 | 2003-10-28 | Merck Frosst Canada & Co. | Tri-aryl-substituted-ethane PDE4 inhibitors |
| AU2001261962B2 (en) | 2000-05-25 | 2005-04-21 | Merck Frosst Canada Ltd | Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor |
| US6740666B2 (en) | 2000-12-20 | 2004-05-25 | Merck & Co., Inc. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| JP4460221B2 (ja) | 2001-05-24 | 2010-05-12 | メルク フロスト カナダ リミテツド | １−ビアリール−１，８−ナフチリジン−４−オン系ホスホジエステラーゼ−４阻害薬 |
| ES2320204T3 (es) * | 2001-05-29 | 2009-05-20 | Bayer Schering Pharma Aktiengesellschaft | Pirimidinas inhibidoras de cdk, su preparacion y su utilizacion como medicamentos. |
| JO2311B1 (en) | 2001-08-29 | 2005-09-12 | ميرك فروست كندا ليمتد | Alkyl inhibitors Ariel phosphodiesterase-4 |
| EP1594863A1 (en) * | 2003-02-11 | 2005-11-16 | Prosidion Limited | Tri(cyclo) substituted amide glucokinase activator compounds |
| EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Ｐｄｅ阻害による神経新生の調節 |
| WO2007053596A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| WO2008030651A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2257272B1 (cs) * | 1974-01-15 | 1978-08-25 | Pharmascience Labo | |
| US4193926A (en) * | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
| DE2413935A1 (de) * | 1974-03-20 | 1975-10-16 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone |
| DE2541855A1 (de) * | 1975-09-18 | 1977-03-31 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone ii |
| SU888821A3 (ru) * | 1976-12-03 | 1981-12-07 | Шеринг Аг (Инофирма) | Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов |
| ATE798T1 (de) * | 1978-06-15 | 1982-04-15 | Imperial Chemical Industries Plc | Entzuendungshemmende 1-phe nyl-2-aminoaethanol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen zur oertlichen anwendung. |
| US5128358A (en) * | 1988-01-19 | 1992-07-07 | Pfizer Inc. | Aryl substituted nitrogen heterocyclic antidepressants |
| FI875724L (fi) * | 1986-04-29 | 1987-12-28 | Pfizer | Av kalcium oberoende camp fosfodiesteras-inhibitordepressant. |
| US4792561A (en) * | 1986-05-29 | 1988-12-20 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors |
| US4921862A (en) * | 1986-05-29 | 1990-05-01 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors |
| US5274002A (en) * | 1987-04-14 | 1993-12-28 | Warner-Lambert Company | Trisubstituted phenyl analogs having activity for congestive heart failure |
| US4971959A (en) * | 1987-04-14 | 1990-11-20 | Warner-Lambert Company | Trisubstituted phenyl analogs having activity for congestive heart failure |
| EP0393500A1 (de) * | 1989-04-17 | 1990-10-24 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue Arylpyridazine, ihre Herstellung, Verwendung und sie enthaltende Arzneimittel |
| DE4003919A1 (de) * | 1990-02-09 | 1991-08-14 | Basf Ag | Heteroarylalkene, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung |
| GB9007762D0 (en) * | 1990-04-05 | 1990-06-06 | Beecham Group Plc | Novel compounds |
| AU7854291A (en) * | 1990-04-27 | 1991-11-27 | Rorer International (Holdings), Inc. | Styryl compounds which inhibit egf receptor protein tyrosine kinase |
| BR9106653A (pt) * | 1990-07-10 | 1993-06-08 | Smithkline Beecham Corp | Oxamidas |
| US5124455A (en) * | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
| WO1992006085A1 (en) * | 1990-09-28 | 1992-04-16 | Smith Kline & French Laboratories Limited | Phenylpyridinol derivatives as medicaments |
| US5376656A (en) * | 1990-10-16 | 1994-12-27 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Arylpyridazinones |
| AU9030691A (en) * | 1990-11-06 | 1992-05-26 | Smithkline Beecham Corporation | Imidazolidinone compounds |
| GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
| IE71647B1 (en) * | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
| WO1992019602A1 (de) * | 1991-04-26 | 1992-11-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue pyridazine |
| US5191084A (en) * | 1991-05-01 | 1993-03-02 | American Home Products Corporation | Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents |
| PT100441A (pt) * | 1991-05-02 | 1993-09-30 | Smithkline Beecham Corp | Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso |
| EP0540165A1 (en) * | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkanoic acid derivatives |
| CA2080554A1 (en) * | 1991-10-15 | 1993-04-16 | Mitsubishi Chemical Corporation | Styrene derivatives |
| US5326898A (en) * | 1992-02-11 | 1994-07-05 | Allergan, Inc. | Substituted phenylethenyl compounds having retinoid-like biological activity |
| WO1993019748A1 (en) * | 1992-04-02 | 1993-10-14 | Smithkline Beecham Corporation | Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
| ES2227519T3 (es) * | 1992-07-28 | 2005-04-01 | Aventis Pharma Limited | Inhibidores de c-amp-fosfodiesterasa. |
| DK0672031T3 (da) * | 1992-12-02 | 2003-06-10 | Pfizer | Catecholdiethere som selektive PDE IV-inhibitorer |
| TW263495B (cs) * | 1992-12-23 | 1995-11-21 | Celltech Ltd |
-
1993
- 1993-12-22 GB GB939326173A patent/GB9326173D0/en active Pending
-
1994
- 1994-12-21 US US08/361,439 patent/US5608070A/en not_active Expired - Lifetime
- 1994-12-22 CA CA002177817A patent/CA2177817A1/en not_active Abandoned
- 1994-12-22 EP EP95903885A patent/EP0736010A1/en not_active Withdrawn
- 1994-12-22 CZ CZ19961819A patent/CZ294296B6/cs not_active IP Right Cessation
- 1994-12-22 WO PCT/GB1994/002799 patent/WO1995017386A1/en not_active Ceased
- 1994-12-22 AU AU12783/95A patent/AU689837B2/en not_active Ceased
- 1994-12-22 JP JP7517279A patent/JPH09510691A/ja active Pending
- 1994-12-22 FI FI962599A patent/FI962599A0/fi not_active IP Right Cessation
- 1994-12-22 KR KR1019960703333A patent/KR100328191B1/ko not_active Expired - Fee Related
- 1994-12-22 GB GB9612213A patent/GB2299082B/en not_active Expired - Lifetime
- 1994-12-22 NZ NZ277529A patent/NZ277529A/en not_active IP Right Cessation
- 1994-12-22 HU HU9601725A patent/HUT76284A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1278395A (en) | 1995-07-10 |
| CZ294296B6 (cs) | 2004-11-10 |
| AU689837B2 (en) | 1998-04-09 |
| GB9326173D0 (en) | 1994-02-23 |
| FI962599L (fi) | 1996-06-20 |
| US5608070A (en) | 1997-03-04 |
| WO1995017386A1 (en) | 1995-06-29 |
| JPH09510691A (ja) | 1997-10-28 |
| EP0736010A1 (en) | 1996-10-09 |
| HU9601725D0 (en) | 1996-08-28 |
| GB9612213D0 (en) | 1996-08-14 |
| KR100328191B1 (ko) | 2002-07-27 |
| GB2299082B (en) | 1998-06-17 |
| GB2299082A (en) | 1996-09-25 |
| FI962599A7 (fi) | 1996-06-20 |
| CZ181996A3 (en) | 1997-02-12 |
| CA2177817A1 (en) | 1995-06-29 |
| HUT76284A (en) | 1997-07-28 |
| NZ277529A (en) | 1998-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962599A0 (fi) | Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksi | |
| DE69526182D1 (de) | Verfahren zur Herstellung von Trehalosederivaten | |
| FI924569A7 (fi) | Menetelmä fenyyli-isoseriinijohdannaisten enantioselektiiviseksi valmi stamiseksi | |
| FI103666B1 (fi) | Menetelmä bifenyylijohdannaisen valmistamiseksi | |
| NO20001728D0 (no) | Fremgangsmåte for fremstilling av chirale forbindelser | |
| DE69619067D1 (de) | Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten | |
| FI942907A0 (fi) | Menetelmä lipaasin valmistamiseksi | |
| DE69635421T2 (de) | Verfahren zur herstellung von 2-chlorthiazolderivaten | |
| DE59308715D1 (de) | Verfahren zur Herstellung von Dimethylchlorsilan | |
| FI942102A0 (fi) | Menetelmä alumiinioksaanien valmistamiseksi | |
| DE69325675D1 (de) | Verfahren zur Herstellung von Amid-Verbindungen und Mikroorganismus dafür | |
| DE59505811D1 (de) | Verfahren zur Herstellung von Methylchlorsilanen | |
| NO941056L (no) | Fremgangsmåte for fremstilling av organoklorsilaner | |
| DE69305828D1 (de) | Verfahren zur Herstellung von 2-Iminothiazolin-Derivaten und Verfahren zur Herstellung ihrer Zwischenprodukte | |
| NO179244C (no) | Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal | |
| NO941967D0 (no) | Fremgangsmåte for enantioselektivsyntesen for mellomprodukter anvendt i fremstillingen av fysostigmin | |
| DE69304637D1 (de) | Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan | |
| DE69628060D1 (de) | Verfahren zur Herstellung von Difluormethan und Difluorchlormethan | |
| DE69431537D1 (de) | Verfahren zur Herstellung von 5-Trifluormethyluracil-Derivaten | |
| FI942888A0 (fi) | Menetelmä pyranyylisyaaniguanidiinijohdanaisten valmistuksessa käyttökelpoisten välituotteiden valmistamiseksi | |
| FI102841B (fi) | Menetelmä mannitolin valmistamiseksi | |
| DE69311220D1 (de) | Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan | |
| FI961178A0 (fi) | Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi | |
| DE59405997D1 (de) | Verfahren zur Herstellung von Hydroxyalkylaminonitrobenzol-Derivaten | |
| DE59407470D1 (de) | Verfahren zur Herstellung von Methylchlorsilanen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |